TELFAST ORAL SUSPENSION 6 MG/ML [SIN14199P]
Active ingredients: TELFAST ORAL SUSPENSION 6 MG/ML
Last updated 24 April 2026
Product Info
TELFAST ORAL SUSPENSION 6 MG/ML
[SIN14199P]
Product information
Active Ingredient and Strength | FEXOFENADINE 28 MG/5 ML EQV FEXOFENADINE HYDROCHLORIDE - 30 MG/5 ML |
Dosage Form | SUSPENSION |
Manufacturer and Country | SANOFI MEDLEY FARMACÊUTICA LTDA. - BRAZIL |
Registration Number | SIN14199P |
Licence Holder | OPELLA HEALTHCARE SINGAPORE PTE. LTD. |
Forensic Classification | PRESCRIPTION ONLY MEDICINES |
Anatomical Therapeutic Chemical (ATC) code | R06AX26 |
Prescription-only Medicines with Exemptions for Supply without Prescription | As an oral liquid preparation not exceeding 6mg/ml
|
Indication
INDICATIONS
Relief of symptoms associated with chronic idiopathic urticaria from 6 months of age.
Relief of symptoms associated with allergic rhinitis from 2 years of age.
Dosing
DOSE AND ADMINISTRATION
Paediatrics
Allergic Rhinitis:
Children aged 2 to 11 years: 30 mg twice daily, when required.
Chronic Idiopathic Urticaria:
Children aged 6 to 23 months: 15 mg twice daily, when required.
Children aged 2 to 11 years: 30 mg twice daily, when required.
Shake the bottle well before administering.
Contraindications
CONTRAINDICATIONS
Telfast is contraindicated in patients with a known hypersensitivity to fexofenadine, terfenadine or any of its excipients.